Gilead Sciences Inc (GIS) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB +0,12%	1 095,11	+1,30	+0,12%	—	1 093,81	1 096,52	1 100,22	1 093,20	—	—
SIXC Communications SIXC Communications	SIXC +0,16%	609,72	+0,95	+0,16%	—	608,77	608,77	612,97	608,77	—	—
SIXE Energy SIXE Energy	SIXE −1,21%	1 239,67	−15,14	−1,21%	—	1 254,81	1 253,01	1 253,87	1 226,33	—	—
SIXI Industrials SIXI Industrials	SIXI −0,69%	1 748,89	−12,22	−0,69%	—	1 761,11	1 764,27	1 766,88	1 745,39	—	—
SIXM Financials SIXM Financials	SIXM −0,15%	641,60	−0,98	−0,15%	—	642,58	644,87	648,48	641,41	—	—
SIXR Staples SIXR Staples	SIXR −0,39%	847,83	−3,30	−0,39%	—	851,13	855,66	858,75	845,56	—	—
SIXRE Real estate SIXRE Real estate	SIXRE −0,37%	217,16	−0,81	−0,37%	—	217,98	217,98	218,65	216,88	—	—
SIXT Technology SIXT Technology	SIXT +1,49%	3 259,64	+47,81	+1,49%	—	3 211,83	3 227,21	3 267,76	3 226,55	—	—
SIXU Utilities SIXU Utilities	SIXU −0,68%	942,52	−6,46	−0,68%	—	948,98	948,58	957,83	941,97	—	—
SIXV Health care SIXV Health care	SIXV −0,24%	1 470,91	−3,61	−0,24%	—	1 474,52	1 479,03	1 481,04	1 469,17	—	—
SIXY Discretionary SIXY Discretionary	SIXY +0,51%	2 404,28	+12,16	+0,51%	—	2 392,12	2 396,95	2 421,22	2 382,32	—	—

GIS:FRA

Gilead Sciences Inc

109,66 €

−0,71%

(−0,78) 1 D

30. apr., 22:00:00 GMT+2 · EUR

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for GIS …

Åpne

109,64 €

Høy

109,66 €

Lav

109,64 €

Markedsverdi

164,08 mrd.

Snittvolum

338,00

Volum

0,00

52 u høy

132,00 €

52 u lav

82,61 €

Antall ansatte

17k

Relaterte aksjer

Nyhetssaker

Fra kilder på nettet

Zacks Investment Research

for 1 time siden

Should You Buy, Hold, or Sell GILD Stock Ahead of Q1 Earnings?

MarketBeat

for 7 timer siden

Gilead Sciences, Inc. $GILD Shares Sold by New York State Teachers Retirement System

Stock Titan

for 9 timer siden

Gilead executives line up four investor conference talks through June 9

Insider Monkey

for 23 timer siden

Is Gilead Sciences, Inc. (GILD) A Good Stock To Buy Now?

Profil

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. It has recently expanded into different therapeutic areas such as oncology and inflammation. Gilead is a member of the Nasdaq-100 and the S&P 100. Gilead was founded in 1987 under the name Oligogen by Michael L. Riordan. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs like Tamiflu and Vistide that decade. In the 2000s, Gilead received approval for drugs including Viread and Hepsera, among others. It began evolving from a biotechnology company into a pharmaceutical company, acquiring several subsidiaries, though it still relied heavily on contracting to manufacture its drugs. The company continued its growth in the 2010s. Wikipedia

Om Gilead Sciences Inc

Administrerende direktørDaniel O'Day

Ansatte17k

Grunnlagt22. juni 1987

HovedkontorFoster City, California, USA

Sektor-

Nettstedgilead.com

Alle verdier i USD	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	6,67 mrd.	7,08 mrd.	7,77 mrd.	7,92 mrd.
Varekostnad	1,54 mrd.	1,50 mrd.	1,57 mrd.	1,62 mrd.
Direkte driftskostnader	1,54 mrd.	1,50 mrd.	1,57 mrd.	1,62 mrd.
Utgifter til forskning og utvikling	1,34 mrd.	1,45 mrd.	1,33 mrd.	1,57 mrd.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	1,22 mrd.	1,36 mrd.	1,35 mrd.	1,78 mrd.
Driftskostnader	2,56 mrd.	2,81 mrd.	2,69 mrd.	3,34 mrd.
Totale driftskostnader	4,10 mrd.	4,31 mrd.	4,26 mrd.	4,96 mrd.
Driftsinntekter	2,57 mrd.	2,77 mrd.	3,51 mrd.	2,96 mrd.
Andre ikke-operasjonelle inntekter	11,00 mill.	13,00 mill.	−23,00 mill.	51,00 mill.
EBT inkludert uvanlige elementer	1,65 mrd.	2,43 mrd.	3,64 mrd.	2,08 mrd.
EBT uten uvanlige elementer	2,40 mrd.	2,58 mrd.	3,34 mrd.	2,80 mrd.
Kostnad for inntektsskatt	334,00 mill.	468,00 mill.	589,00 mill.	−105,00 mill.
Faktisk avgiftssats	20,25 %	19,28 %	16,18 %	−5,05 %
Andre driftskostnader	-	-	-	-
Nettoinntekt	1,32 mrd.	1,96 mrd.	3,05 mrd.	2,18 mrd.
Netto fortjenestemargin	19,72 %	27,68 %	39,28 %	27,55 %
Resultat per aksje	1,81	2,01	2,47	1,86
Rente- og investeringsinntekter	94,00 mill.	73,00 mill.	88,00 mill.	95,00 mill.
Rentekostnader	−260,00 mill.	−254,00 mill.	−256,00 mill.	−255,00 mill.
Netto rentekostnader	−166,00 mill.	−181,00 mill.	−168,00 mill.	−160,00 mill.
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	3,26 mrd.	3,46 mrd.	4,20 mrd.	3,65 mrd.
Gevinst eller tap ved salg av eiendeler	-	-	-	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning